PEAK6
TXG icon

PEAK6’s 10x Genomics TXG Stock Holding History

PEAK6’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6K Sell
500
-20,000
-98% -$400K ﹤0.01% 2535
2025
Q4 		$334K Buy
20,500
+1,700
+9% +$25.7K ﹤0.01% 2252
2025
Q3 		$220K Buy
+18,800
New +$245K ﹤0.01% 2432

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6's TXG Position: Q1 2026 in Review

PEAK6 opened a new position in 10x Genomics (TXG) in Q1 2026: 81,424 shares worth $1.73M. The stake represents ﹤0.01% of the portfolio and ranks #1443 among its holdings.

329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • PEAK6 held 81,424 shares of 10x Genomics worth $1.73M as of Q1 2026.
  • 10x Genomics was a new PEAK6 position in Q1 2026.
  • 10x Genomics made up ﹤0.01% of PEAK6's portfolio in Q1 2026, its #1443 holding.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.